Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?
JAMA Intern Med
; 181(10): 1278-1280, 2021 10 01.
Article
in En
| MEDLINE
| ID: mdl-34254992
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Medicare
/
Device Approval
/
Alzheimer Disease
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
JAMA Intern Med
Year:
2021
Document type:
Article